ClinicalTrials.Veeva

Menu

Surgical Correction of Moderate Ischemic Mitral Regurgitation

S

Shaare Zedek Medical Center

Status

Completed

Conditions

Moderate Ischemic Mitral Regurgitation

Treatments

Procedure: mitral valve annuloplasty

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Exclusion criteria

  • etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems